This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 06/29/2020
Location: Virtual
Subject: Listening Session with Natural Products Association (NPA)
FDA Participant/Group: SHERENE SEPEHRI; SHARON MAYL; KAREN MEISTER; KAVEETA VASISHT; APRIL ALEXANDROW; ALISON THOMPSON; MICHAEL LEVY; LOWELL SCHILLER; STEVEN TAVE; DOUGLAS TICKER; MICHAEL ADAMS; REBECCA GOLDBERG; EMILY ROSE CAREY; MICHELLE ADAMS; DOMINIC CHIAPPERINO; PATRICK COURNOYER; PAUL HART; DENNIS KEEFE; TRISTAN COLONIUS;
Non FDA Participant/Group: Daniel Fabricant, Kyle Turk, Sibyl Swift, Steve Northrup (Natural Products Association);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/29/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives from across the food and beverage industry

Event Date: 07/01/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR;
Non FDA Participant/Group: Mark Killian (Arizona Department of Agriculture);

Event Date: 07/02/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: REBECCA BUCKNER; KARI IRVIN; NINA ZIMDAHL; ANDREW KENNEDY; CAITLIN BOON;
Non FDA Participant/Group: George Atkinson, NiCole Bice (Institute on Science for Global Policy);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/01/2020
Location: Virtual
Subject: Shellfish Equivalency Project
FDA Participant/Group: ANNE KIRCHNER, ALLESANDRO FIORELLI
Non FDA Participant/Group: Aikaterini Argiri, Matthew Hudson (European Union Representative);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/29/2020
Location: Virtual
Subject: Development of Individualized Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Multidisciplinary members of the National Institute of Neurological Disorders and Stroke

Event Date: 06/30/2020
Location: Virtual
Subject: Moving Toward Global Regulatory Convergence for Advanced Therapy Medicinal Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Parenteral Drug Association

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event